Skip to content

Dokter Schepers

Active
Private limited companyfounded 2014active for 11 yearsMorgensterdreef 2, 8490 Jabbeke, BelgiumKBO/BCE: BE 0507.838.649
Summary

Dokter Schepers has been active since 2014 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €23,685 and a net result of €147,408. Equity is shrinking by about 3.8% per year across the filed financial years. Its solvency ranks better than 18% of 3,007 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Risk analysisFollow ReportCompare
Dokter SchepersActiveChecked score 93/100
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
1 site
Size
€156,257total assets 2025
Equity
€23,685
Profit
€147,408
Turnover not published (abbreviated or micro format)
Financial health
93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
2025 accounts 19 days early1 of 5 deeds summarised
Why 93raises riskEquity €23,685 (15.2% of total assets)lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.06, cash €140,480Size: total assets €156,257Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 45% of its sector peers (NACE 86, micro)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 40+1
equity 15.2% of total assets
Liquidity 53+1
short-term debt 84.8% · cash 89.9%
Profitability 100=
return on assets 94.3%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,112 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: 0.1%▲ +0.1 percentage points vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025highest value 09-2025: < 0.1%▼ -0.1 percentage points vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €2,000 on 30-day terms is acceptable
Liquidity tight (current ratio 1.06, compared with 0.98 in 2024, below the usual 1.5; short-term debt: 84.8% and cash: 89.9% of total assets), and 84.8% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 17% on solvency, 27% on liquidity, 80% on profitability and 54% on growth.

The bankruptcy probability was computed on 23-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Seven signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.06, cash €140,480
NBB · annual accounts
lowers risk · Size: total assets €156,257
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
raises risk · Equity €23,685 (15.2% of total assets)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 18% of 3007 sector peers (2025).
NBB · sector comparison
Position among 3007 sector peers
Solvency
better than 18%
← weakest strongest →
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year €23,685
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 12-07-2026, 19 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
19 days early
2024
8 days late
2023
7 days late
2022
7 days late
2021
33 days early
2020
6 days late
2019
45 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 3 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 7 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
24-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Highest result from 2018 to 2025net €147,408 ▲17.2%
  3. Annual accounts filedfinancial year 2024 · micro…

Key points

  • Caution: Among the weakest 13% on equitysector median €369,013 · 3,007 companies €23,685 View
  • Positive: 8 profitable years in a rowprofit 2025: €147,408 8 years View
  • Total assets 20256 financial years filed €156,257 View

By topic

Financials

Financial year
2025
Total assets
€156,257
Profit
€147,408
Solvency
15.2%
Total assets▲ 2.1%
Net result
20182025
Go to Financials

Timeline

Events
13
Since
2016
Next accounts
by 31-07-2027
  1. 07-08-2024Annual accounts filed
  2. 27-11-2023Capital & shares · Amendment of the…
  3. 07-08-2023Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
30-12-2014
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
27
Purpose
“De uitoefening van de genees-, heel- en verloskunde en meer in het bijzonder de…” (deed in Dutch)
Go to Articles of association

Key facts about Dokter Schepers

What is the company number of Dokter Schepers?
0507.838.649. In Belgium the VAT number is the company number with BE in front: BE 0507.838.649.
Where is Dokter Schepers based?
The registered office is at Morgensterdreef 2, 8490 Jabbeke.Company details
What does Dokter Schepers do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dokter Schepers?
Private limited company (BV).
When was Dokter Schepers founded?
On 30-12-2014.
Is Dokter Schepers still active?
Yes, Dokter Schepers is an active enterprise in the KBO register.
What is the turnover of Dokter Schepers?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
Is Dokter Schepers profitable?
In financial year 2025, Dokter Schepers made a profit of €147,408.
Where can I find the annual accounts of Dokter Schepers?
Dokter Schepers filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dokter Schepers due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to Dokter Schepers

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure